The Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Iclepertin (BI 425809): Results from Two Phase I Open-Label, Non-randomised, Single Dose, Parallel Design Studies
肾功能或肝功能损害对伊克利帕汀(BI 425809)药代动力学的影响:两项 I 期开放标签、非随机、单剂量、平行设计研究的结果
期刊:Drugs in Research & Development
影响因子:2.1
doi:10.1007/s40268-026-00537-w
Choi, HeeJae; Madari, Shilpa; Daalman, Elmar; English, Brett A; Halabi, Atef; Hohl, Kathrin; Shatillo, Yury; Weidinger, Nathalie; Desch, Michael